Utilizing 25 primary prostate tumors and a combination of immunoblotting, ELISA, and IHC, Royuela et al. reported that phospho-p38 (p-p38) is upregulated in prostate tumors (149). The gene discussed is MAPK14; the disease is prostate neoplasm.